Trial Profile
Phase II Study of TLC D-99 for Hepatobiliary Carcinomas
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Filgrastim
- Indications Cholangiocarcinoma; Gallbladder cancer; Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 22 Sep 2005 New trial record.